Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole for Refractory Invasive Fungal Infections
NCT00034658Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 1998
- Primary completion
- Mar 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of posaconazole in invasive fungal infection (IFI), sponsored by Merck & Co.. Started Dec 1998; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00034658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034658.